tirzepatide microdosing before and after Microdose Tirzepatide: Biomarker-Guided Weight Loss Strategy – PlexusDx Microdosing GLP-1s: A Doctor's Guide

WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use

However, discharge characteristics can vary, and some women experience minimal discharge despite significant symptoms

Do not use GSH if you are pregnant or breastfeeding

Community reports describe reduced soreness duration and improved exercise tolerance, consistent with IGF-1-mediated muscle repair becoming noticeable